Jul 15, 2024 | Advocacy, Diabetes Business, Featured, Podcasts, Research News, Technology Updates, Videos
Novo’s once-weekly insulin rejected by FDA by Kristin Jensen for BioPharmaDive.com, 11 July 2024. Novo is one of the world’s premier manufacturers, along with Indianapolis-based Eli Lilly. Both have been working for years to offer patients a more convenient option...
Jul 1, 2024 | Diabetes Business, Podcasts, Research News, Technology Updates
Senseonics tips 365-day CGM to double 2025 sales by Nick Paul Taylor for MedTechDive.com, 25 June 2024. In 2024, Senseonics expects to more than double U.S. new patient starts and increase the global installed base by around 50%. The growth is built on the current...
Jun 17, 2024 | Diabetes Business, Featured, Podcasts, Research News, Technology Updates
FDA approves Abbott’s Lingo and Libre Rio glucose monitoring systems by Archana Rani for MedicalDevice-Network.com, June 2024. The US Food and Drug Administration (FDA) has approved Abbott’s Lingo and Libre Rio over-the-counter continuous glucose monitoring (CGM)...
May 28, 2024 | Advocacy, Diabetes Business, Featured, Foods, Podcasts, Research News, Technology Updates
FDA approves hybrid closed-loop insulin delivery app from CamDiab by Sean Whooley for DrugDelieveryBusiness.com, 24 May 2024. CamDiab announced today that the FDA granted authorization for its CamAPS FX advanced adaptive closed-loop artificial pancreas app. CamAPS FX,...
May 20, 2024 | Advocacy, Diabetes Business, Featured, LOOPing, Podcasts, Research News, Technology Updates, Videos
Meet the newest insulin pump: all about “twiist” with Sequel CEO Alan Lotvin by Stacey Simms for Diabetes-Connections.com, 16 April 2024. This week, the newest pump coming to the market is called the twiist. It’s a very different shape – circular with a top half that...
Feb 5, 2024 | Diabetes Business, Featured, Podcasts, Technology Updates
Lilly, Novo could be first trillion-dollar health stocks: world’s largest sovereign wealth fund by Dulan Lokuwithana for SeekAlpha.com, 31 January 2024. Weight loss drugmakers Eli Lilly and Novo Nordisk could be the first healthcare stocks to achieve the $1T...